THERAPEUTICSMD INC (TXMD) Stock Cash Flow
NASDAQ:TXMD - Nasdaq - US88338N2062 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -2.10M | -2.18M | -10.28M | 112.00M | -172.42M | |||
| Depreciation Amortization | 471.00K | 509.00K | 922.00K | 1.19M | 740.00K | |||
| Change In Working Capital | 2.48M | 1.66M | -17.45M | -4.09M | 4.59M | |||
| Interest Paid | N/A | N/A | 0.00 | 13.55M | 25.07M | |||
| Other non cash items | 551.00K | 744.00K | -21.34M | -113.18M | 24.40M | |||
| OPERATING CASH FLOW | 1.41M | 732.00K | -48.14M | -4.08M | -142.69M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | -360.00K | -2.22M | |||
| Other Investing Activity | N/A | N/A | 0.00 | 223.83M | 0.00 | |||
| INVESTING CASH FLOW | N/A | N/A | 0.00 | 223.48M | -2.22M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | -219.43M | -50.00M | |||
| Stock Issued/Repurchased | N/A | N/A | 3.15M | -14.51M | 184.67M | |||
| Other Financing Activity | N/A | 0.00 | N/A | -1.27M | -5.12M | |||
| FINANCING CASH FLOW | N/A | 0.00 | 3.15M | -235.21M | 129.55M | |||
| CHANGE IN CASH | 1.41M | 732.00K | -44.99M | -15.81M | -15.36M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 1.41M | 732.00K | -48.14M | -4.08M | -142.69M | |||
| Capital Expenditure | N/A | N/A | 0.00 | -360.00K | -2.22M | |||
| FREE CASH FLOW | 1.41M | 732.00K | -48.14M | -4.44M | -144.91M | |||
All data in USD